At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:24 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 37,293,854 shares of Sana Biotechnology common stock as of September 30, 2026, representing 12.5% of shares outstanding. This is a routine passive stake update by a major institutional holder; no change in investment intent is indicated.
- FMR LLC reported beneficial ownership of 37,293,854 shares of Sana Biotechnology common stock as of September 30, 2026.
- The stake represents 12.5% of the outstanding shares.
- Fidelity Growth Company Commingled Pool held 15,131,616 shares (5.1%) of the total outstanding as of the same date.
- The filing is an amendment to a Schedule 13G, confirming passive investment intent under Rule 13d-1(c).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access